| SpectraBase Spectrum ID |
JI8Nys4NUHY |
| Name |
N-(3,4-Methylenedioxyphenylprop-2-yl)-1,3-oxazolidine |
| Classification |
Amphetamine analog designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
235.120843408 u |
| Formula |
C13H17NO3 |
| InChI |
InChI=1S/C13H17NO3/c1-10(14-4-5-15-8-14)6-11-2-3-12-13(7-11)17-9-16-12/h2-3,7,10H,4-6,8-9H2,1H3 |
| InChIKey |
RHIGUBSSZMGUKL-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
235.283 g/mol |
| Nominal Mass |
235 u |
| Quality |
987 |
| Retention Index |
1880 |
| SMILES |
C=12C(=CC(CC(N3CCOC3)C)=CC1)OCO2 |
| SPLASH |
splash10-0udi-4900000000-55b63f47a17987059514 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
3-(1-(1,3-benzodioxol-5-yl)propan-2-yl)-1,3-oxazolidine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_002787 |
